Targeting the CCL2–CCR2 axis for atheroprotection

MK Georgakis, J Bernhagen, LH Heitman… - European heart …, 2022 - academic.oup.com
Decades of research have established atherosclerosis as an inflammatory disease. Only
recently though, clinical trials provided proof-of-concept evidence for the efficacy of anti …

Inflammatory chemokines in atherosclerosis

S Gencer, BR Evans, EPC van der Vorst, Y Döring… - Cells, 2021 - mdpi.com
Atherosclerosis is a long-term, chronic inflammatory disease of the vessel wall leading to the
formation of occlusive or rupture-prone lesions in large arteries. Complications of …

Macrophage migration inhibitory factor family proteins are multitasking cytokines in tissue injury

S Song, Z Xiao, FJ Dekker, GJ Poelarends… - Cellular and Molecular …, 2022 - Springer
The family of macrophage migration inhibitory factor (MIF) proteins in humans consist of MIF,
its functional homolog D-dopachrome tautomerase (D-DT, also known as MIF-2) and the …

Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune‐mediated diseases

C Britton, MC Poznansky, P Reeves - The FASEB Journal, 2021 - Wiley Online Library
Historically the chemokine receptor CXCR4 and its canonical ligand CXCL12 are
associated with the bone marrow niche and hematopoiesis. However, CXCL12 exhibits …

Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting

C Kontos, O El Bounkari, C Krammer, D Sinitski… - Nature …, 2020 - nature.com
Targeting a specific chemokine/receptor axis in atherosclerosis remains challenging.
Soluble receptor-based strategies are not established for chemokine receptors due to their …

Hallmarks of cancer affected by the MIF cytokine family

R Mora Barthelmess, B Stijlemans… - Cancers, 2023 - mdpi.com
Simple Summary The aim of this review is to summarize the available information regarding
the MIF family in cancer, comprising MIF and DDT. Both cytokines are highly expressed in …

Macrophage migration inhibitory factor (MIF) makes complex contributions to pain-related hyperactivity of nociceptors after spinal cord injury

A Bavencoffe, EA Spence, MY Zhu… - Journal of …, 2022 - Soc Neuroscience
Neuropathic pain is a major, inadequately treated challenge for people with spinal cord
injury (SCI). While SCI pain mechanisms are often assumed to be in the CNS, rodent studies …

Proteolysis targeting chimera (PROTAC) for macrophage migration inhibitory factor (MIF) has anti‐proliferative activity in lung cancer cells

Z Xiao, S Song, D Chen, R van Merkerk… - Angewandte Chemie …, 2021 - Wiley Online Library
Macrophage migration inhibitory factor (MIF) is involved in protein‐protein interactions that
play key roles in inflammation and cancer. Current strategies to develop small molecule …

CD74 is a functional MIF receptor on activated CD4+ T cells

L Zhang, I Woltering, M Holzner, M Brandhofer… - Cellular and Molecular …, 2024 - Springer
Next to its classical role in MHC II-mediated antigen presentation, CD74 was identified as a
high-affinity receptor for macrophage migration inhibitory factor (MIF), a pleiotropic cytokine …

Rutin hydrate relieves neuroinflammation in zebrafish models: involvement of NF-κB pathway as a central network

Y Hu, K Jia, Y Zhou, L Chen, F Wang, X Yi… - Fish & Shellfish …, 2023 - Elsevier
Neuroinflammation is prevalent in multiple brain diseases and may also lead to dementia,
cognitive impairment, and impaired spatial memory function associated with …